Corteva (NYSE:CTVA) Issues FY 2026 Earnings Guidance

Corteva (NYSE:CTVA) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 3.600-3.800 for the period, compared to the consensus EPS estimate of 3.740. The company issued revenue guidance of -, compared to the consensus revenue estimate of $18.3 billion.

Corteva Trading Down 11.6%

NYSE CTVA traded down $10.36 during trading hours on Friday, reaching $78.98. The company had a trading volume of 11,529,474 shares, compared to its average volume of 3,285,966. The stock has a 50-day moving average of $82.15 and a 200 day moving average of $79.55. Corteva has a 1-year low of $60.53 and a 1-year high of $90.97. The stock has a market capitalization of $52.83 billion, a P/E ratio of 52.31, a price-to-earnings-growth ratio of 2.70 and a beta of 0.56. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The company had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.24%. The business’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, research analysts anticipate that Corteva will post 3.76 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva’s dividend payout ratio is 42.35%.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on CTVA shares. UBS Group dropped their price objective on Corteva from $90.00 to $86.00 and set a “neutral” rating on the stock in a report on Tuesday, June 9th. Zacks Research raised shares of Corteva from a “hold” rating to a “strong-buy” rating in a report on Monday, July 13th. Citigroup raised their price target on Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. The Goldman Sachs Group upped their target price on Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a research note on Tuesday, April 14th. Finally, Morgan Stanley lifted their target price on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $90.19.

Key Headlines Impacting Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Corteva reported second-quarter adjusted EPS of $2.30, exceeding the $2.24 analyst consensus and rising from $2.20 a year earlier. Seed pricing, productivity improvements, demand for newer genetics and traits, and growth in Crop Protection products supported margins. Reuters earnings report
• Positive Sentiment: The company raised its fiscal 2026 EPS outlook to $3.60-$3.80, reflecting strong first-half performance, operating improvements and growth platforms. Management also said it remains on track for the planned October 1 Vylor spin-off, a potential catalyst for improved business focus and valuation. Corteva first-half results and outlook
• Positive Sentiment: Analyst commentary remains broadly constructive: Corteva has outperformed the broader market and agriculture-focused ETFs, while brokerages maintain a consensus “Moderate Buy” rating. Momentum-focused analysis also highlights the company’s improving execution and fundamentals. Brokerage consensus rating
• Neutral Sentiment: Despite the earnings beat and higher guidance, one analysis argues that much of Corteva’s improved execution is already reflected in the stock, leaving limited upside unless earnings growth accelerates. Corteva valuation analysis
• Negative Sentiment: Second-quarter revenue was $6.38 billion, below the $6.60 billion consensus and down 1.2% year over year. The sales miss, together with competitive pricing pressure, appears to be the main reason the stock moved lower despite the profit beat and raised outlook. Corteva second-quarter earnings summary

Institutional Trading of Corteva

A number of institutional investors and hedge funds have recently made changes to their positions in CTVA. Invesco Ltd. increased its position in Corteva by 16.7% in the fourth quarter. Invesco Ltd. now owns 11,404,960 shares of the company’s stock worth $764,474,000 after buying an additional 1,630,712 shares during the period. Axxcess Wealth Management LLC lifted its position in Corteva by 1.2% in the 4th quarter. Axxcess Wealth Management LLC now owns 31,120 shares of the company’s stock valued at $2,086,000 after purchasing an additional 355 shares during the last quarter. Corient Private Wealth LLC boosted its stake in Corteva by 4.8% during the 4th quarter. Corient Private Wealth LLC now owns 203,950 shares of the company’s stock valued at $13,422,000 after purchasing an additional 9,388 shares during the period. Ameriflex Group Inc. increased its stake in shares of Corteva by 14,875.0% in the fourth quarter. Ameriflex Group Inc. now owns 599 shares of the company’s stock valued at $40,000 after purchasing an additional 595 shares during the period. Finally, Mercer Global Advisors Inc. ADV raised its holdings in shares of Corteva by 3.8% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 71,499 shares of the company’s stock valued at $4,793,000 after buying an additional 2,620 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.